[Inflammatory markers in heart failure].
Heart failure is a leading cause of cardiovascular mortality and morbidity. It has been shown that inflammatory markers may play a role in the pathogenesis of heart failure. Therefore, inflammatory markers and anticytokine therapy in heart failure have become the attractive subjects in the literature. There are new studies regarding this issue in the literature. In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.
Ozmen
Namik
N
GATA Haydarpaşa Eğitim Hastanesi, Kardiyoloji Servisi, Istanbul, Türkiye. drnamikozmen@yahoo.com
Cebeci
Bekir Sitki
BS
Kardeşoğlu
Ejder
E
D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000037:antagonists & inhibitors; D003937:Diagnosis, Differential; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D015415:Biomarkers; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha